These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
12 Jun, 2026, 12.25 PM IST
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
22 Apr, 2026, 11.33 AM IST
Zydus Lifesciences gets USFDA approval for angina, high blood pressure drugZydus Lifesciences has secured USFDA approval to market Diltiazem Hydrochloride tablets, used for treating angina and high blood pressure, ...
11 Aug, 2025, 12.59 PM IST
Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals Ltd has secured final approval from the USFDA for its generic Diltiazem Hydrochloride extended-release capsules. Th...
11 Nov, 2024, 01.17 PM IST
Alembic Pharma gets USFDA nod for generic hypertension treatment capsulesAlembic Pharmaceuticals has received USFDA final approval for its generic Diltiazem Hydrochloride extended-release capsules in strengths of...
21 Oct, 2024, 02.08 PM IST
Granules India gets USFDA nod for generic Prazosin Hydrochloride capsulesThe US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals...
28 Dec, 2021, 12.16 PM IST
Alembic Pharmaceuticals gets USFDA nod for anti-depressant drugThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Desipram...
08 Jul, 2021, 01.55 PM IST
Granules gets American drug regulator's nod for diabetes management drug MetforminThe US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metfor...
13 Jan, 2021, 12.45 PM IST
Alembic gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity"The company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tiz...
15 Jan, 2020, 11.36 AM IST
Alembic gets USFDA nod for Vilazodone Hydrochloride tablets used to treat depression"The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Viibryd tablets, 10 mg, 20 mg, and 40 mg, of A...
13 Jan, 2020, 11.40 AM IST
Aurobindo Pharma gets US FDA nod for Alzheimer's drug Memantine HydrochlorideAurobindo Pharma said it has received final approval from the US FDA to manufacture and market Memantine Hydrochloride used in treatment of...
15 Oct, 2015, 11.45 AM IST
Dr Reddy's announces launch of OTC tablets in US marketDr Reddy's Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg is available in a 20 count ...
20 Nov, 2014, 07.35 PM IST
- Dr Reddy’s Laboratories launches Parkinson’s drug in US
Dr Reddy’s has launched in the US mkt ropinirole hydrochloride XR (extended release) tablets used to treat the signs & symptoms of Parkinso...
08 Jun, 2012, 05.50 AM IST
- Sun Pharma gets USFDA nod to market generic Uroxatral tablets
The company's Alfuzosin Hydrochloride 10-mg tablets are therapeutically equivalent to drug-maker Sanofi-Aventis' Uroxatal extended release ...
19 Jul, 2011, 02.11 PM IST
- Dr Reddy's launches hypertension capsules Amlodipine Besylate and Benazepril Hydrochloride capsules in US market
Dr Reddy's Laboratories on Thursday said it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules in the US market.
07 Jul, 2011, 01.09 PM IST